Taveras Arthur
Insider CIK 1830901 · XFOR Chief Scientific Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| XFOR X4 Pharmaceuticals, Inc | S Sale | 2024-10-07 | 2024-10-08 | 76,920 | $0.56 | $43.1K | 388,026 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award | 2024-10-04 | 2024-10-08 | 230,645 | — | $0 | 464,946 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | S Sale | 2024-03-11 | 2024-03-11 | 14,235 | $0.88 | $12.5K | 234,301 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award deriv | 2024-02-13 | 2024-02-16 | 428,248 | — | $0 | 428,248 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | S Sale | 2024-02-12 | 2024-02-12 | 787 | $1.01 | $795 | 248,536 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | S Sale | 2023-11-01 | 2023-11-03 | 67,695 | $0.73 | $49.4K | 249,323 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award | 2023-10-31 | 2023-11-02 | 230,645 | — | $0 | 317,018 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | S Sale | 2023-03-10 | 2023-03-13 | 16,806 | $0.84 | $14.1K | 86,373 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | S Sale | 2023-02-13 | 2023-02-15 | 928 | $0.93 | $863 | 103,179 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award deriv | 2022-11-07 | 2022-11-09 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award | 2022-03-01 | 2022-03-01 | 97,000 | — | $0 | 104,107 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | F Tax w/h | 2022-02-11 | 2022-02-14 | 928 | — | $0 | 7,107 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award | 2021-03-24 | 2021-03-25 | 8,035 | — | $0 | 8,035 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award deriv | 2020-11-30 | 2020-12-01 | 121,150 | $6.60 | $799.6K | 121,150 | SEC↗ |